Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.

[1]  Kazunari Yoshida,et al.  [Revised WHO Classification of Tumours of the Central Nervous System:Summary of the Revision and Perspective]. , 2016, No shinkei geka. Neurological surgery.

[2]  C. Shieff,et al.  WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment , 2016, Journal of Neuro-Oncology.

[3]  J. Farah,et al.  Early adjuvant radiotherapy in the treatment of atypical meningioma , 2016, Journal of Clinical Neuroscience.

[4]  J. Barnholtz-Sloan,et al.  American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. , 2016, Neuro-oncology.

[5]  M. Mehta,et al.  Atypical meningioma: randomized trials are required to resolve contradictory retrospective results regarding the role of adjuvant radiotherapy. , 2015, Journal of cancer research and therapeutics.

[6]  Rory K. J. Murphy,et al.  Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. , 2014, Neurosurgery.

[7]  Rory K. J. Murphy,et al.  Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection. , 2014, Neurosurgery.

[8]  P. Eldridge,et al.  Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment , 2014, Acta Neurochirurgica.

[9]  B. Pollock Defining the best management for patients with intracranial World Health Organization grade II meningiomas. , 2014, World neurosurgery.

[10]  C. James,et al.  Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. , 2014, Neuro-oncology.

[11]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[12]  M. Jenkinson,et al.  Atypical meningoma: current management dilemmas and prospective clinical trials , 2014, Journal of Neuro-Oncology.

[13]  R. Mair,et al.  Simpson grade: an opportunity to reassess the need for complete resection of meningiomas , 2014, Acta Neurochirurgica.

[14]  E. Air,et al.  Atypical meningiomas: is postoperative radiotherapy indicated? , 2013, Neurosurgical focus.

[15]  C. Brennan,et al.  The role of radiotherapy following gross-total resection of atypical meningiomas. , 2012, Journal of neurosurgery.

[16]  A. von Deimling,et al.  Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. , 2011, International journal of radiation oncology, biology, physics.

[17]  R. Mair,et al.  Radiotherapy for atypical meningiomas. , 2011, Journal of neurosurgery.

[18]  M. Berger,et al.  The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. , 2010, Journal of neurosurgery.

[19]  Jung-Il Lee,et al.  Treatment of atypical meningioma , 2010, Journal of Clinical Neuroscience.

[20]  D. Louis,et al.  Genomic Profiling of Atypical Meningiomas Associates Gain of 1q With Poor Clinical Outcome , 2009, Journal of neuropathology and experimental neurology.

[21]  W. Curry,et al.  LONG‐TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION , 2009, Neurosurgery.

[22]  B. Guthrie,et al.  Hitting a moving target : evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria A case series , 2008 .

[23]  T. Santarius,et al.  Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine? , 2008, British journal of neurosurgery.

[24]  D. Kong,et al.  Relationship between malignant subtypes of meningioma and clinical outcome , 2007, Journal of Clinical Neuroscience.

[25]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[26]  J. Schramm,et al.  Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  P. Gutin,et al.  Diagnosis and Treatment of Atypical and Anaplastic Meningiomas: A Review , 2005, Neurosurgery.

[28]  C. Hess,et al.  Atypical and anaplastic meningiomas — does the new WHO-classification of brain tumours affect the indication for postoperative irradiation? , 2005, Acta Neurochirurgica.

[29]  Sang‐wook Lee,et al.  Treatment Results of Postoperative Radiation Therapy for Malignant and Atypical Meningioma. , 2002, Cancer research and treatment : official journal of Korean Cancer Association.

[30]  G. Barnett,et al.  Local control and overall survival in atypical meningioma: a retrospective study. , 2000, International journal of radiation oncology, biology, physics.

[31]  B. Scheithauer,et al.  Meningioma grading: an analysis of histologic parameters. , 1997, The American journal of surgical pathology.

[32]  J M Buatti,et al.  Benign meningiomas: primary treatment selection affects survival. , 1997, International journal of radiation oncology, biology, physics.